Table 1.

Liver function tests for the groups treated with or without CCl₄ or MSC-Smad7 for 21 days

Group	Number	ALT(U/L)	AST(U/L)	ALB (g/dl)	TP (g/dl)
Control	6	26.8 ± 9.2	66.9 ± 7.8	43.7 ± 9.1	70.7 ± 7.4
CCl4-treated	6	128.6 ± 10.3***	138.4 + 6.1***	23.4 ± 8.6**	43.8 + 6.4***
CCl4+MSC	6	119.6 ± 10.1***	135.7 ± 6.8***	22.8 ± 8.1**	44.9 ± 6.3***
CCl4+MSC-Smad7	6	65.3 ± 11.9*, ###	82.9 ± 7.7**,###	31.7 ± 7.1*	63.6 ± 5.3###

ALT alanine transaminase, AST aspartate transaminase, ALB albumin, TP total protein. *P < 0.05, **P < 0.01 and ***P < 0.001 comparing with the control group. ^#P < 0.05, ^##P < 0.01 and ^###P < 0.001 comparing with the CCl₄-treated group